Ejulir 6 mg/ml solution for injection in pre-filled pen
Authorisation PA23266/080/001 · Viatris Limited
- Licence holder
- Viatris Limited (all products →)
- Active substance
- Liraglutide
- Clinical trials
- 8 clinical trials →
- Dosage form
- Solution for injection in pre-filled pen
- Route of administration
- Subcutaneous use
- ATC code
- A10BJ02
- First authorised
- 06/02/2026
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Hybrid application (Article 10(3) of Directive No 2001/83/EC)
Liraglutide: supply and approvals
6 authorised products on the HPRA list contain Liraglutide. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
-
Victoza: Shortage ongoing, first published 3 Aug 2023
Saxenda: Shortage resolved, first published 24 Aug 2023 - US shortage (FDA)
- Liraglutide Injection: in shortage, updated 22 Sep 2026
- Germany (BfArM)
- 1 supply notice, e.g. Victoza 6 mg/ml Injektionslösung in Fertigpen - OP(2x3ml) (9 Jul 2026 to 31 Mar 2027)
- Recent EMA authorisation
- Ablymico, 15 Jul 2026, STADA Arzneimittel AG
Liraglutide STADA, 15 Jul 2026, STADA Arzneimittel AG
Registers: EU shortages · US shortages · German shortages · EMA approvals
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 12 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.